Coated medical device
First Claim
1. A method for making a drug-coated angioplasty device, comprising:
- applying a solution comprising paclitaxel directly to the surface of a polymeric balloon wall of a balloon of an angioplasty device and drying the solution to form a coating comprising paclitaxel directly on the polymeric balloon wall to provide an outermost surface over the balloon, and wherein the coating is free from any containment material for the paclitaxel; and
processing said angioplasty device to be suitable for insertion into a patient with said coating providing said outermost surface.
4 Assignments
0 Petitions
Accused Products
Abstract
A coated medical device (10) including a structure (12) adapted for introduction into a passage or vessel of a patient. The structure is formed of preferably a non-porous base material (14) having a bioactive material layer (18) disposed thereon. The medical device is preferably an implantable stent or balloon (26) of which the bioactive material layer is deposited thereon. The stent can be positioned around the balloon and another layer of the bioactive material posited over the entire structure and extending beyond the ends of the positioned stent. The ends of the balloon extend beyond the ends of the stent and include the bioactive material thereon for delivering the bioactive material to the cells of a vessel wall coming in contact therewith. The balloon further includes a layer of hydrophilic material (58) positioned between the base and bioactive material layers of the balloon.
216 Citations
8 Claims
-
1. A method for making a drug-coated angioplasty device, comprising:
-
applying a solution comprising paclitaxel directly to the surface of a polymeric balloon wall of a balloon of an angioplasty device and drying the solution to form a coating comprising paclitaxel directly on the polymeric balloon wall to provide an outermost surface over the balloon, and wherein the coating is free from any containment material for the paclitaxel; and processing said angioplasty device to be suitable for insertion into a patient with said coating providing said outermost surface. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. A method for making a drug-coated angioplasty device, comprising:
-
applying a solution comprising paclitaxel directly to a surface of an angioplasty device and drying the solution to form a coating comprising paclitaxel directly on the surface of the angioplasty device to provide an outermost surface over the angioplasty device, wherein the coating is free from any containment material for the paclitaxel, and wherein said surface is a balloon wall surface of the angioplasty device; and processing said angioplasty device to be suitable for insertion into a patient with said coating providing said outermost surface.
-
-
8. A method for making an angioplasty device useful for applying paclitaxel to a wall of a vascular vessel of a patient, the angioplasty device having an outermost surface for contact with the wall of the vascular vessel, the method comprising:
processing an angioplasty device so as to be suitable for insertion into a patient to perform an angioplasty, wherein the processed angioplasty device has an outermost coating comprising paclitaxel, the outermost coating positioned on a portion of the device that contacts the wall of the vascular vessel upon conduct of an angioplasty procedure with the angioplasty device, and the outermost coating being free from any containment material for the paclitaxel, wherein said processing includes applying a solution comprising paclitaxel directly to a base material of the device portion and drying the solution to form said outermost coating, and wherein said device portion is a balloon.
Specification